Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-07-24
2009-06-02
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S300100, C548S311100
Reexamination Certificate
active
07541375
ABSTRACT:
The invention provides substituted pyrazolidinone compounds, and methods of treatment and pharmaceutical compositions that utilize or comprise one or more such compounds. Compounds of the invention are useful for a variety of therapies, including treating or preventing various cancers, inflammation, septic shock, preterm labor, infertility, pain, and ischemia, and other diseases and disorders associated with MEK-1 and/or ERK-2 activation.
REFERENCES:
patent: 6579872 (2003-06-01), Brown et al.
patent: 6599910 (2003-07-01), Adams et al.
patent: 7253199 (2007-08-01), Arkinstall et al.
patent: 99/59959 (1999-11-01), None
patent: 00/10563 (2000-03-01), None
Julie A. Spicer, Expert Opin. Drug Discov., vol. 3(7), 2008, 801-817, especially p. 812.
K. Murali Krishna Rao, et al., Journal of Toxicology and Environmental Health, Part A, vol. 65, pp. 757-768, 2002.
Carl Johanson, et al., ACTA Endocrinologica, vol. 117, pp. 497-506, 1988.
Johannes L. Bos, Cancer Research, vol. 49, pp. 4682-4689, Sep. 2, 1989.
Vimala S. Sivaraman, et al., J. Clin. Invest. vol. 99, No. 7, pp. 1478-1483, 1997.
Georg Schett, et al., Arthritis & Rheumatism, vol. 43, No. 11, pp. 2501-2512, 2000.
Shella M. Thomas, et al., Cell, vol. 68, pp. 1031-1040, Mar. 20, 1992.
Kenneth W. Wood, et al., Cell, vol. 68, pp. 1041-1050, Mar. 20, 1992.
Elisabeth Genot, et al., Current Opinion in Immunology, vol. 12, pp. 289-294, 2000.
Sam J. Mansour, et al., Science, vol. 265, pp. 966-970, Aug. 12, 1994.
C. Dominique Toran-Allerand, et al., Frontiers in Neuroendocrinology, vol. 20, pp. 97-121, 1999.
Sally Cowley, et al., Cell, vol. 77, pp. 841-852, Jun. 17, 1994.
Mariano Barbacid, Ann. Rev. Biochem. vol. 56, pp. 779-827, 1987.
Korotkikh, M. Synthesis of 2- and 5-unsubstituted imidazole salts, Ukrainskii Khimicheskii Zhurnal, 2001, vol. 67, Issues 11-12, pp. 97-103. See STN Notes.
Sommerdijk, J.A.J.M. Aziridines as Precursors for Chiral Amide-Containing Surfactants, J. Org. Chem., 1997, vol. 62, pp. 4955-4960, expecially p. 4958.
Arkinstall Stephen J.
Arulanandam Antonio
Blume-Jensen Peter
Jiang Xuliang
Magar Sharad
Chung Susannah
Laboratoires Serono SA
Oblon & Spivak, McClelland, Maier & Neustadt P.C.
Shameem Golam M. M.
LandOfFree
Azole derivatives and pharmaceutical compositions containing... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azole derivatives and pharmaceutical compositions containing..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azole derivatives and pharmaceutical compositions containing... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4064054